Dr. Lauren Sari Zaretsky, MD

Dr. Zaretsky practices at Long Island Digestive Endoscopy Center, LLC in Port Jefferson Station, New York.

Dr. Zaretsky's NPI, 1700867546, was assigned on November 9, 2005. Dr. Zaretsky graduated from Icahn School Of Medicine At Mount Sinai in 1988. Dr. Zaretsky holds New York license 179592-1.

Dr. Zaretsky's primary practice is Long Island Digestive Endoscopy Center, LLC, at 1500 State Rte 112, Port Jefferson Station, NY 11776 in Suffolk County. The practice phone is (631) 828-3400.

Dr. Zaretsky's primary practice is Long Island Digestive Endoscopy Center, LLC in Port Jefferson Station, New York. Dr. Zaretsky is also affiliated with Mather Hospital. The medical group on file is ENT and Allergy Associates. Dmand AI also links Dr. Zaretsky to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zaretsky practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Zaretsky's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Zaretsky is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Zaretsky's licenses on file in 3 states: New York, California and New Jersey.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease and swimmer's ear among the conditions Dr. Zaretsky treats.

CMS data shows 2,002 Medicare services from Dr. Zaretsky across 11 procedure codes in 2024, for 855 Medicare patients. Medicare paid $186,119 for them. Every service was in an office.

CMS counts 855 Medicare patients who saw Dr. Zaretsky in 2024. The largest group is 65 to 74, with 342 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zaretsky's median patient age at 61, with 60% women.

In 2024, Dr. Zaretsky wrote 1,244 Medicare Part D claims for 426 patients. 95% of them were for generic drugs. CMS names the drug for 1,158 of them, across 20 drugs with 11 or more claims each, at $193,032 in total drug cost. In 2023, CMS named 963 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Zaretsky for performance year 2024, reported as part of a group. Dr. Zaretsky accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Zaretsky. Dr. Zaretsky's most frequent co-authors are Max M. April, MD, Sujana S. Chandrasekhar, MD and Harold C. Pillsbury, MD.

CMS Open Payments shows 243 general payments to Dr. Zaretsky from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Inspire Medical Systems, Inc. paid the most, $1,032.

Dmand AI lists 4 awards for Dr. Zaretsky, most recently Presidential Citation in 2016. Dr. Zaretsky serves on Regent Registry Executive Committee.

Dr. Zaretsky graduated from Icahn School Of Medicine At Mount Sinai in 1988. Dr. Zaretsky is a member of NHS, ACS, AMA and Long Island Society of Otolaryngology.

Dr. Zaretsky is in network with 12 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.